Drugs: Pressemitteilungen - Kategorie - Seite 29

Drugs

Category / Pharmaceuticals & Biotech / Drugs


New PSA Reminds College Students That Vaccination Is the Best Form of Protection Against Dangerous Flu Virus

KING OF PRUSSIA, PA: College Population's Low Vaccination Rates, High-Touch Living Spaces Pose Increased Risk ...

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Pediatric Schizophrenia

PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 11/24/14 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery ...

New Federal Funding Enables CDRD and CDRD Ventures Inc. to Expand Support to Canadian Entrepreneurs

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/21/14 -- This morning at the BC Technology Industry Association, The Honourable James Moore, Minister of Industry announced that The Centre for Drug ...

Marina Biotech Reports That Partner Mirna Therapeutics Presented Interim Phase 1 Data on Its First-in-Class microRNA-34 Mimic

BOTHELL, WA: SMARTICLES(R) Formulated MRX34 Was Found to Have a Manageable Safety Profile in Two Different Treatment Regimens ...

Insys Therapeutics to Present at 26th Annual Piper Jaffray Healthcare Conference

PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 11/19/14 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery ...

VANC Pharmaceuticals Receives NPNs From Health Canada For 4 Products

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/19/14 -- VANC Pharmaceuticals Inc. ("Vanc" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF) is pleased to announce that it ha ...

Medifocus Inc.'s Form 20-F Registration Statement Becomes Effective Immediately

COLUMBIA, MD and TORONTO, ON: COLUMBIA, MD and TORONTO, ON -- (Marketwired) -- 11/19/14 -- (OTCQX: MDFZF) (TSX VENTURE: MFS) announced today that its Registration Statement on Form 20-F that was filed with the U.S. Securities and ...

Knight Sells Priority Review Voucher to Gilead

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 11/19/14 -- Knight Therapeutics Inc., (TSX: GUD) through one of its wholly owned subsidiaries ("Knight"), today announced the sale of its Neglected Tro ...

Vanc Pharmaceuticals Receives Health Canada Approval for 22 Generic Molecules

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/18/14 -- Vanc Pharmaceuticals Inc. ("Vanc" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF) is pleased to announce that it ha ...

Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance

PRINCETON, NJ and REHOVOT, ISRAEL and BOTHELL, WA: Clinical Study Intended to Identify Novel microRNA Candidates for the Treatment of Duchenne Muscular Dystrophy ...

Merus Labs International Inc. Announces Normal Course Issuer Bid

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/17/14 -- Merus Labs International Inc. ("Merus" or the "Company") (TSX: MSL)(NASDAQ: MSLI) announced today that it is proceeding with a no ...

Matica Enterprises Inc.: Corporate Update on Completed Nova Scotia MMPR Facility With "Ready to Build" Status

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/14/14 -- Matica Enterprises Inc. (CSE: GRF)(FRANKFURT: 39N) ("Matica" or the "Company") is pleased to provide an update on the signing of ...

Cleveland BioLabs and Roswell Park Cancer Institute Announce Publication of Studies Demonstrating Curaxin CBL0137's Ability to Eradicate Drug-Resistant Cancer Stem Cells and Potentiate Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer

BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 11/13/14 -- (NASDAQ: CBLI) today announced the publication of studies in Oncotarget describing the preclinical efficacy of Curaxin CBL0137 as a single agent and in com ...

Horizon Pharma plc Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets and VIMOVO(R) (Naproxen/Esomeprazole Magnesium) to Be Presented at the American College of Rheumatology Annual Meeting

DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 11/12/14 -- Horizon Pharma plc (NASDAQ: HZNP) today announced that four abstracts related to RAYOS (prednisone) delayed-release tablets and one abstract on VIMOVO ...

Knight Reports Third Quarter 2014 Results

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 11/12/14 -- Knight Therapeutics Inc. ("Knight") (TSX: GUD) today reported its financial results for the quarter ended September 30, 2014.Third Quarter ...

Insys Therapeutics Reports Third Quarter 2014 Financial Results

PHOENIX, AZ: $58.3 Million in Net Revenue Versus $29.2 Million in Q3 2013; Cash, Cash Equivalents, and Investments Up at the End of Quarter to $89.5 Million ...

SciClone Reports Financial Results for the Third Quarter 2014

FOSTER CITY, CA: 2014 EPS Guidance Revised Upward; ZADAXIN(R) Leads Continued Growth of Core Business in 2014 ...

TraceLink Unveils One-Week DSCSA Compliance Solution for Pharmaceutical Supply Chain

WAKEFIELD, MA: Companies Struggling to Develop ASN/Paper Solutions Internally or with 3PL Providers Now Have Streamlined and More Affordable Path to Meet January 1 Deadline ...

Dynavax Announces Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM)

BERKELEY, CA: BERKELEY, CA -- (Marketwired) -- 11/10/14 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the independent Data and Safety Monitoring Board (DSMB) charged with periodically rev ...


Seite 30 von 66:  « ..  29 30 31  32  33  34  35  36  37  38  .. » 66





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z